Health system C-suites are approaching a pivotal inflection point. By 2030, leaders will be navigating an environment defined by persistent margin pressure, workforce scarcity, accelerating digital ...
The past few decades have seen a dramatic shift in how human disorders can be treated. Growing knowledge of the molecular dynamics underlying physiological processes and technological advances are ...
The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback